Article info

Original article
Benefits and harms of roflumilast in moderate to severe COPD
Free

Authors

  1. Correspondence to Professor Milo Puhan, Institute of Social and Preventive Medicine, University of Zurich, Hirschengraben 84, Zurich CH-8001, Switzerland; milo.puhan{at}ifspm.uzh.ch
View Full Text

Citation

Yu T, Fain K, Boyd CM, et al
Benefits and harms of roflumilast in moderate to severe COPD

Publication history

  • Received July 8, 2013
  • Revised November 18, 2013
  • Accepted December 4, 2013
  • First published December 17, 2013.
Online issue publication 
June 10, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.